---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-065442"
form_type: "8-K"
ticker: null
cik: "0001017491"
company_name: "SEELOS THERAPEUTICS, INC."
filed_at: "2023-05-26T23:59:59+00:00"
generated_at: "2026-06-14T12:25:58.615392+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Seelos receives Nasdaq delisting notice; plans to appeal and may pursue reverse stock split

## Summary
- Nasdaq notified Seelos on May 23, 2023 that it failed to regain compliance with $1.00 bid price rule.
- Company is ineligible for a second 180-day compliance period because stockholders' equity is below $5M.
- Seelos will request a hearing by May 30, 2023, staying suspension until the panel rules.
- Hearing plan may include a reverse stock split to regain compliance with Rule 5550(a)(2).
- If appeal is denied, common stock will be delisted from Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001104659-23-065442
- form_type: 8-K
- cik: 0001017491
- company_name: SEELOS THERAPEUTICS, INC.
- filed_at: 2023-05-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1017491/000110465923065442/0001104659-23-065442-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1017491/000110465923065442/tm2317105d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-065442
- JSON: https://secwatch.observer/filing/0001104659-23-065442.json
- Plain text: https://secwatch.observer/filing/0001104659-23-065442.txt

## Key facts
- Listing & Compliance Notices
  SEELOS THERAPEUTICS, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: May 23, 2023, the Listing Qualifications Staff of Nasdaq (the “Staff”) provided a notice to the Company (the “Nasdaq Notice”) that the Company has not regained compliance with Rule 5550(a)(2) and is not eligible for a second 180 calendar day compliance period as the Company does not comply with the minimum $5,000,000 stockholder’s equity requirement for initial listing on the Nasdaq Capital Market. The Nasdaq Notice further indicated that, unless the Company requests a hearing on an appeal of this determination by the Staff before a Nasdaq Hearings Panel by no later than May 30, 2023, the Comp
  evidence_url: https://www.sec.gov/Archives/edgar/data/1017491/000110465923065442/0001104659-23-065442-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.